Correlation Between Stoke Therapeutics and Mirum Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Mirum Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Mirum Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Stoke Therapeutics and Mirum Pharmaceuticals, you can compare the effects of market volatilities on Stoke Therapeutics and Mirum Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Mirum Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Mirum Pharmaceuticals.

Diversification Opportunities for Stoke Therapeutics and Mirum Pharmaceuticals

-0.01

Correlation Coefficient

Stoke Therapeutics  Mirum Pharmaceuticals

Good diversification

The 3 months correlation between Stoke and Mirum is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Mirum Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mirum Pharmaceuticals and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Mirum Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mirum Pharmaceuticals has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Mirum Pharmaceuticals go up and down completely randomly.

Pair Corralation between Stoke Therapeutics and Mirum Pharmaceuticals

Given the investment horizon of 90 days Stoke Therapeutics is expected to under-perform the Mirum Pharmaceuticals. In addition to that, Stoke Therapeutics is 1.54 times more volatile than Mirum Pharmaceuticals. It trades about -0.09 of its total potential returns per unit of risk. Mirum Pharmaceuticals is currently generating about 0.08 per unit of volatility. If you would invest  4,180  in Mirum Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of  441.00  from holding Mirum Pharmaceuticals or generate 10.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Stoke Therapeutics  vs.  Mirum Pharmaceuticals

Stoke Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Stoke Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Mirum Pharmaceuticals

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Mirum Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Mirum Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Stoke Therapeutics and Mirum Pharmaceuticals

The main advantage of trading using opposite Stoke Therapeutics and Mirum Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Mirum Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mirum Pharmaceuticals will offset losses from the drop in Mirum Pharmaceuticals' long position.

The idea behind Stoke Therapeutics and Mirum Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .